Spain
Tuberculosis profile
Population  2012 47 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.27 (0.26–0.27) 0.57 (0.57–0.58)
Mortality (HIV+TB only) 0.066 (0.05–0.095) 0.14 (0.11–0.2)
Prevalence  (includes HIV+TB) 8.1 (3.2–15) 17 (6.8–33)
Incidence  (includes HIV+TB) 6.5 (5.7–7.4) 14 (12–16)
Incidence (HIV+TB only) 0.58 (0.51–0.66) 1.3 (1.1–1.4)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 1 984 (37) Relapse 0 (0)
Smear-negative 1 595 (30) Treatment after failure 0 (0)
Smear-unknown / not done 260 (5) Treatment after default 0 (0)
Extrapulmonary 1 508 (28) Other 314 (100)
Other 0 (0)      
Total new 5 347   Total retreatment 314  
           
Other (history unknown) 330        
Total new and relapse 5 347   Total cases notified 5 991  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.1 1.7 1.2
Age < 15 25 245 73
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 73   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 70  
Retreatment 56  
TB/HIV 2012 Number (%)
TB patients with known HIV status 4 179 (70)
HIV-positive TB patients 370 (9)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.22 (0.03–0.8) 7.1 (3.3–13)
MDR-TB cases among notified pulmonary
TB cases
9 (1–31) 22 (10–41)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 802 (21%) 69 (22%) 871
Laboratory-confirmed MDR-TB cases 26 11 37
Patients started on MDR-TB treatment      
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-16 Data: www.who.int/tb/data